FDA Revises Trial Requirements for Drug and Medical Product Approval - Part 2
In part two of this series, Dr. Justin Abbatemarco and Lizzy Lawrence discuss recent FDA guidance, focusing on broader agency changes and how this messaging differs from the FDA's traditional…
Read the full articleYou might also wanna read
Researchers Call for FDA to Require Negative Drug Studies on Product Labels After Approval of Drug with Mostly Negative Results
Researchers urge inclusion of negative studies on drug labels
medpagetoday.com·18d ago
People’s Pharmacy: FDA is changing prescribing info for testosterone replacement therapy. Here’s what to know
Have low T? FDA is loosening it's labeling rules.
FDA Proposes Revised Payor Communications Draft Guidance to Formally Include Devices and Reflect New Statutory Safe Harbor While Balancing Substantial Government Interests
The U.S. Food and Drug Administration’s 2026 Draft Payor Guidance would update the framework for communications between drug and device manu
FDA Accepts New Drug Application for Oral Investigational Treatment in RRMM – Bristol Myers Squibb
Bristol Myers Squibb, shared a post on LinkedIn: “The U.S. FDA has accepted a New Drug Application for our second oral investigational treat
FDA Proposes New Registration and Listing Pathway for Distributed Manufacturing and Aligns Foreign Establishment Obligations With Current Law
On July 13, 2026, the U.S. Food and Drug Administration (FDA) published a proposed rule that would amend the drug establishment registration
Regulatory renewal needed for UK life sciences ambitions
A new report, 'Enhancing the role of UK medicine regulation' sets out key recommendations to rebuild the UK’s world-class reputation in regu
Comments
Sign in to join the conversation.
No comments yet. Be the first.